Study guide

6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing

Utah MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC

1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel

2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel

3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement

4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing

4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags

5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records

5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards

6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration

6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting

7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs

7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security

9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database

9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)

10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products

10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales

11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery

11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs

12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards

13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation

13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits

6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing

Key Takeaways Explain This Topic AI

A Utah pharmacist or intern may dispense a self-administered hormonal contraceptive under a standing order only to a patient who is 18 or older (Utah Code § 26B-4-504(1)).

Covered methods are FDA-approved oral contraceptives, the hormonal vaginal ring, and the hormonal patch; they do not include any drug intended to induce an abortion.

Before dispensing, the pharmacist or intern must obtain a completed Utah self-screening risk-assessment questionnaire and must refer the patient instead of dispensing if it shows dispensing is unsafe (Utah Code § 26B-4-506(1)).

Utah requires evidence of a visit with a primary care or women's health practitioner in the preceding 24 months before a pharmacist may continue dispensing beyond 24 months after the initial prescription (Utah Code § 26B-4-506(1)(c)).

Participating pharmacists complete a DOPL-approved ACPE training program, enroll with DHHS (re-enrolling every two years), and complete two hours of related CE each renewal cycle.

Last updated: September 2026

6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing

Utah's pharmacist-provided hormonal contraception program rests on three layers of law:

Statute: Title 26B, Chapter 4, Part 5 (§§ 26B-4-503 to -507), the "Treatment Access" provisions, and § 58-17b-502(1)(n);

DHHS rule and standing order: R433-200 and the Utah Statewide Standing Order for Pharmacist Dispensing of Hormonal Contraception ; and

DOPL rules and guidance: R156-17b-610(8), R156-17b-621b, and the Utah Guidance for Self-Administered Hormonal Contraceptives incorporated through R156-17b-627 (pharmacist prescribing under § 58-17b-627).

Who and what

Who may provide it: a pharmacist or pharmacy intern licensed under the Pharmacy Practice Act who has completed the required training (§ 26B-4-504; R156-17b-621b).

Patient age: 18 years or older (§ 26B-4-504(1); DOPL guidance). Utah has no pharmacist pathway for minors, even with a prior prescription.

Covered products: FDA-approved oral hormonal contraceptives , the hormonal vaginal ring , and the hormonal contraceptive patch . Excluded are any drug intended to induce an abortion, and methods that are not self-administered (injectable medroxyprogesterone, implants, IUDs).

Participation is voluntary. The statutes create no duty or standard of care to prescribe or dispense (§ 26B-4-503).

Standing order mechanics (§ 26B-4-505; R433-200)

A physician (including a DHHS physician or a local health department medical director) may issue a standing order under a protocol that identifies authorized dispensers by license number , requires the physician to review their dispensing practices at least annually , requires dispensing records, and is approved by DHHS rule.

R433-200-3 requires records of each patient's age and ZIP code , the NDC dispensed, and an annual count of self-screening assessments evaluated.

The physician who issues the standing order is not liable for civil damages from dispensing under it (§ 26B-4-507).

Training, enrollment, and CE

Requirement Detail

Initial training An ACPE-accredited program on dispensing self-administered hormonal contraceptives, approved by DOPL with the board , completed and documented before any dispensing (R156-17b-621b)

DOPL guidance Review the Utah Guidance for Self-Administered Hormonal Contraceptives (R156-17b-621b(2)(c))

DHHS enrollment Enroll at the DHHS birth control program site after training, re-enroll every two years , and update enrollment when adding or removing a pharmacy location (standing order)

  • CE Two hours of related CE in each renewal cycle after initial training (R156-17b-621b; R156-17b-309(1)(f))
  • The encounter (§ 26B-4-506; R156-17b-610(8); standing order)

Self-screening questionnaire. Obtain the patient's completed Utah Hormonal Contraceptive Self-Screening Risk Assessment Questionnaire (English and Spanish versions are available) before dispensing. Use the Standard Procedures Algorithm and the CDC's U.S. Medical Eligibility Criteria (US MEC) . The algorithm includes a blood pressure check.

If unsafe, don't dispense. If the evaluation shows dispensing would be unsafe, the pharmacist or intern may not dispense and must refer the patient to a primary care or women's health practitioner.

Initial dispensing. The standing order allows up to 12 months at the initial dispensing.

Counseling (§ 26B-4-506(2)). At a minimum: administration and storage, side effects and risks, the need for backup contraception , when to seek emergency care , and the risk of STIs and ways to reduce it.

Written information (§ 26B-4-506(1)(d)). Explain the importance of seeing a primary care or women's health practitioner for recommended tests and screening, and the effectiveness and availability of long-acting reversible contraceptives (LARC) . Give the patient a copy of the encounter record , including the completed self-assessment and a description of what was dispensed or why nothing was dispensed.

Abuse concerns. The DOPL guidance directs pharmacists to refer any patient who may be subject to abuse to an appropriate social services agency.

Continuing therapy

Statute: a pharmacist or intern may not continue dispensing for more than 24 months after the initial prescription without evidence the patient has consulted a primary care or women's health practitioner during the preceding 24 months (§ 26B-4-506(1)(c)).

Standing order schedule: re-evaluate at 12, 24, 36, and 48 months , then every 12 months . The 36- and 48-month reviews require evidence of a clinician consult within the last 24 months. If an enrolled pharmacist isn't on site, no standing-order dispensing may occur.

Records and reporting

Records: keep a record of each person seeking the medication (name and age, NDC, dispensing dates, completed self-assessment, counseling given, and any referral) for seven years at the pharmacy where the patient received care (standing order).

Annual reporting: each enrolled pharmacist or intern reports to DHHS within 10 business days after each enrollment year ends . A report is due even if nothing was dispensed. Reports cover dispensing date, contraceptive type and brand, patient age, and ZIP code.

Confidentiality: information collected is confidential "health data" (R433-200-4).

Discipline: failing to follow the Treatment Access statutes when dispensing under a standing order is unprofessional conduct (§ 58-17b-502(1)(n)).

Exam traps

A 17-year-old requesting pills: refer . Utah requires patients to be 18 or older.

Depo-Provera, implants, and IUDs: not self-administered, so not covered.

A 36-year-old who smokes 15 or more cigarettes a day: estrogen-containing methods are US MEC Category 4 . Follow the algorithm (consider a progestin-only pill if appropriate) or refer.